Latest - Public Health & Prevention

• Bond, James Bond, Has a Drinking Problem and Needs Help, Study Shows With a drinking problem at the severe end of the spectrum, 007 would benefit from alcohol education and a supportive workplace culture that provides strategies for managing workplace stress.
  Medscape Medical News, December 2018
• Alert Omega-3 Meds Not Effective After MI, EMA Panel Concludes EMA review finds omega-3 fatty acid medicines are not effective for secondary prevention after myocardial infarction and rules they should no longer be authorized for such use.
  News Alerts, December 2018
• Identity Crisis: Data Misuse An Unseen Twist in DNA Testing
  Reuters Health Information, December 2018
• With No Antiretrovirals, Venezuela HIV Patients Rely on Leaf Remedy As Venezuela's hyperinflation and chronic medicine shortages leave HIV patients with little hope of obtaining antiretroviral drugs, many are now relying on the leaves of a tropical tree known as the guasimo.
  Reuters Health Information, December 2018
• Physician Exclusions From Medicare, Medicaid Increasing
  Medscape Medical News, December 2018
• Depression, PTSD in Women Tied to Subsequent Dementia Women with depression, posttraumatic stress disorder, or traumatic brain injury are 50% to 80% more likely to develop dementia, suggests a new study of more than 100,000 US female veterans.
  Medscape Medical News, December 2018
• Age-Related Macular Degeneration: 5 Things to Know A guide to the latest on this chronic disease, from emerging treatments to the risk factors to be on the lookout for.
  Medscape Ophthalmology, December 2018
• AAAP 2018Sleep Disorder Drug May Be Effective for Stimulant Abuse Modafinil, a wakefulness-promoting agent approved for narcolepsy, obstructive sleep apnea, and shift work sleep disorder, shows promise in treating stimulant use disorders.
  Medscape Medical News, December 2018
• Congress Votes to Legalize Hemp, Cuts Schedule I Classification Congress has passed the 2018 Farm Bill, which includes a provision to make hemp an agricultural commodity by removing it from the federal list of controlled substances.
  Medscape Medical News, December 2018
• Rethinking Conversations on Prognosis and Life Expectancy Talking to patients about end-of-life care is tricky for any physician, especially when the patient doesn't want to talk about it either.
  Medscape Medical News, December 2018
• Overuse of Cardiac Testing This case study highlights inappropriate use of diagnostic tests to screen for cardiac disease in asymptomatic patients, which may lead to unnecessary costly and potentially harmful procedures.
  American Family Physician, December 2018
• Use of E-Cigarettes and Tobacco Products Among Students This report detailing current prevalence of tobacco product use among adolescents and teens reveals a significant increase in the use of e-cigarettes over the past year.
  Morbidity & Mortality Weekly Report, December 2018
• Why the Reluctance to Use Biosimilar Insulins for Diabetes? As the US FDA announces that it will soon be changing the way it approves biosimilar insulins, Medscape examines why these cheaper versions of branded products are not more widely used in diabetes.
  Medscape Medical News, December 2018
• Opioids, ACA, and 'My Lane' Stoked Physicians' Interest in 2018 A Medscape survey indicates what excited, surprised, and frustrated physicians the most this year.
  Medscape Medical News, December 2018
• Insomnia, Other Sleep Problems Rising in College Students Changes in sleep patterns are common among college students. A study in Norway found increases in insomnia and other sleep problems, especially in female students.
  Medscape Medical News, December 2018
• Normal BMI but High Body Fat After Menopause Tied to Higher Breast Cancer Risk Postmenopausal women with higher body fat levels may be at increased risk for breast cancer, even if their body mass index (BMI) is normal, researchers say.
  Reuters Health Information, December 2018
• Cardiovascular Outcomes Trials Give 'Comforting' Results   Dr Anne Peters gives us her take on the recent CARMELINA, DECLARE-TIMI, and REWIND trials and their cardiovascular outcomes.
  Medscape Diabetes & Endocrinology, December 2018
• Addressing Military Mental Health: A Proposed Solution   Dr Jeffrey Lieberman discusses the current stigma around military mental health and proposes a solution to deliver improved care to our veteran population and their families.
  Medscape Psychiatry, December 2018
• More Fluoroquinolone Safety Concerns How do the most recently identified safety issues affect fluoroquinolones' place in therapy?
  Medscape Pharmacists, December 2018
• Lead--The Problem in Pregnancy That We May Forget   The healthcare community is well aware of the adverse effects of lead on children. But we unfortunately pay less attention to the negative fallout for women of childbearing age.
  Medscape Pediatrics, December 2018